---
figid: PMC8042267__fimmu-12-622934-g004
figlink: pmc/articles/PMC8042267/figure/f4/
number: F4
caption: Therapeutic approaches targeting IL23 and IL17 signaling. Ustekinumab and
  briakinumab specifically blocks the IL12/IL23 subunit p40 in CD patients whereas
  risankizumab, brazikumab, guselkumab and mirikizumab selectively block the unique
  subunit p19. Activated Th17 cells produce large amounts of IL17. Secukinumab directly
  binds to IL17A and thereby inhibits the interaction with the IL17 receptor (IL17R).
  Brodalumab directly binds to the IL17R causing an inhibition of IL17 ligand binding
  (A and F) to their receptor.
pmcid: PMC8042267
papertitle: Role of the IL23/IL17 Pathway in Crohnâ€™s Disease.
reftext: Heike Schmitt, et al. Front Immunol. 2021;12:622934.
pmc_ranked_result_index: '33894'
pathway_score: 0.9504447
filename: fimmu-12-622934-g004.jpg
figtitle: Therapeutic approaches targeting IL23 and IL17 signaling
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8042267__fimmu-12-622934-g004.html
  '@type': Dataset
  description: Therapeutic approaches targeting IL23 and IL17 signaling. Ustekinumab
    and briakinumab specifically blocks the IL12/IL23 subunit p40 in CD patients whereas
    risankizumab, brazikumab, guselkumab and mirikizumab selectively block the unique
    subunit p19. Activated Th17 cells produce large amounts of IL17. Secukinumab directly
    binds to IL17A and thereby inhibits the interaction with the IL17 receptor (IL17R).
    Brodalumab directly binds to the IL17R causing an inhibition of IL17 ligand binding
    (A and F) to their receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL12A
  - IL12B
  - NELFCD
  - IL17A
  - IL17F
  - IL17RA
  - IL23R
  - IL12RB1
  - IL12RB2
genes:
- word: IL12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: Th1
  symbol: TH1
  source: hgnc_alias_symbol
  hgnc_symbol: NELFCD
  entrez: '51497'
- word: IL17A
  symbol: IL17A
  source: hgnc_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: IL17F
  symbol: IL17F
  source: hgnc_symbol
  hgnc_symbol: IL17F
  entrez: '112744'
- word: IL17R
  symbol: IL17R
  source: hgnc_prev_symbol
  hgnc_symbol: IL17RA
  entrez: '23765'
- word: IL23R
  symbol: IL23R
  source: hgnc_symbol
  hgnc_symbol: IL23R
  entrez: '149233'
- word: IL12RB1
  symbol: IL12RB1
  source: hgnc_symbol
  hgnc_symbol: IL12RB1
  entrez: '3594'
- word: IL12RB1
  symbol: IL12RB1
  source: hgnc_symbol
  hgnc_symbol: IL12RB1
  entrez: '3594'
- word: IL12RB2
  symbol: IL12RB2
  source: hgnc_symbol
  hgnc_symbol: IL12RB2
  entrez: '3595'
chemicals: []
diseases: []
figid_alias: PMC8042267__F4
redirect_from: /figures/PMC8042267__F4
figtype: Figure
---
